Invention Grant
- Patent Title: Albumin-free botulinum toxin formulations
-
Application No.: US16175434Application Date: 2018-10-30
-
Publication No.: US11351232B2Publication Date: 2022-06-07
- Inventor: Stewart A. Thompson , Curtis L. Ruegg , Jacob M. Waugh
- Applicant: REVANCE THERAPEUTICS, INC.
- Applicant Address: US CA Newark
- Assignee: REVANCE THERAPEUTICS, INC.
- Current Assignee: REVANCE THERAPEUTICS, INC.
- Current Assignee Address: US CA Newark
- Agency: Ballard Spahr LLP
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K8/49 ; A61K39/08 ; C07K14/33 ; A61K9/14 ; A61K8/60 ; A61K8/64 ; A61Q19/00 ; A61Q19/08 ; A61K8/02 ; A61K8/66 ; A61K8/84 ; A61K8/90 ; A61K9/19 ; A61K47/22 ; A61K47/26 ; A61K47/34 ; A61K47/42
Abstract:
This invention relates to botulinum toxin formulations that are stabilized without the use of any proteinaceous excipients. The invention also relates to methods of preparing and using such botulinum toxin formulations.
Public/Granted literature
- US20190290740A1 Albumin-Free Botulinum Toxin Formulations Public/Granted day:2019-09-26
Information query
IPC分类:
